Advanced Diffusion Magnetic reSonance Prostate Imaging for Reducing Extraneous Biopsies (ASPIRE) - Calibration Component (Multi-centre Scanner Calibration) and Validation Component (Multi-centre Validation) | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Advanced Diffusion Magnetic reSonance Prostate Imaging for Reducing Extraneous Biopsies (ASPIRE) - Calibration Component (Multi-centre Scanner Calibration) and Validation Component (Multi-centre Validation)	Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, Urogenital Neoplasms, disease, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder	Not yet recruiting	Not applicable	2026-09-09		NCT07808528

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Cambridge University Hospitals NHS Foundation Trust	64
Imperial College Healthcare NHS Trust	49
Royal Free Hospital NHS Foundation Trust	36
University College London Hospitals	51
University College, London	222
University Hospital Southampton NHS Foundation Trust	59

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University College London Hospitals NHS Foundation Trust	London	United Kingdom	16